Download - American Head and Neck Society

Scientific Program Thursday, April 29, 2010
1:00 PM - 2:00 PM SCIENTIFIC SESSION #6 PLATINUM ROOM
Moderators: Terry A. Day, MD, David Goldenberg, MD and Christine G. Gourin, MD
1:00 PM S036: DECISION MAKING FOR THE EXTENT OF THYROIDECTOMY IN PATIENTS WITH ATYPICAL
CYTOLOGY. Manish D Shah, MD MPhil FRCSC, Andrew Conrad, Aadil Ahmed, Spiro Eski, MD, Christina MacMillan,
MD, Jeremy L Freeman, MD FRCSC FACS; Mount Sinai Hospital, University of Toronto.
1:08 PM S037: SURGICAL PRACTICE PATTERNS IN THE MANAGEMENT OF PAPILLARY THYROID
MICROCARCINOMA. Arthur W Wu, MD, Marilene B Wang, MD, Chau Nguyen, MD; UCLA Division of Head and Neck
Surgery, Los Angeles, CA, USA; Anacapa Surgical Associates, Ventura, CA, USA.
1:16 PM S038: VOLUME-BASED TRENDS IN THYROID SURGERY. Christine G Gourin, MD, Robert E Bristow, MD, Ralph P
Tufano, MD, Arlene A Forastiere, MD, Wayne M Koch, MD, Timothy M Pawlik, MD; Johns Hopkins Medical Institutions.
1:24 PM Discussion – 6 minutes
1:30 PM S039: PROPHYLACTIC CENTRAL LYMPH NODE DISSECTION FOR CLINICALLY NODE-NEGATIVE
PAPILLARY THYROID MICROCARCINOMA: ITS IMPACT ON POSTOPERATIVE THYROGLOBULIN LEVEL,
RECURRENCES AND COMPLICATIONS. Yoon Kyoung So, MD, Young-Ik Son, MD, Min Young Seo, MD, Gil Jun Lee,
MD, Sang Duk Hong, MD; Inje University Paik Hospital, Samsung Medical Center.
1:38 PM S040: ROUTINE PARATHYROID LOCALIZATION WITH 4-D COMPUTED TOMOGRAPHY/ULTRASOUND IN
PATIENTS WITH HYPERPARATHYROIDISM. David I Kutler, MD, Rachel A Moquete, BA, William I Kuhel, MD, Eli
Kazam, MD; Weill Cornell Medical Center.
1:46 PM S041: INTRAOPERATIVE PARATHYROID HORMONE MONITORING IN PARATHYROIDECTOMY; IS IT
MANDATORY? Aviram Mizrachi, MD, Gideon Bachar, MD, Tuvia Hadar, MD, Raphael Feinmesser, MD, Thomas Shpitzer,
MD; Department of Otorhinolaryngology and Head and Neck Surgery, Rabin Medical Center, Beilinson Campus, Petach
Tikva, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
1:54 PM Discussion – 6 minutes
2:00 PM - 3:10 PM PANEL: ROLE OF SURGERY IN LABORATORY PLATINUM ROOM
THYROID CANCER – SUPPORTED BY CLINICAL DATA?
Panel Moderator: Ashok R. Shaha, MD
Panelists: Quan-Yang Duh, MD, Bryan McIver, MBChB, PhD,
Christopher R. McHenry, MD and Lisa A. Orloff, MD
This panel will discuss issues specifically related to microscopic and laboratory thyroid cancer:
its implications, prognostic value, and treatment choices supported by clinical data.
At the conclusion of this session, participants will be able to:
• To discuss the current explosion of thyroid carcinoma.
• To evaluate diagnostic tests and risk analysis.
• Identify which nodules to biopsy.
• Treatment of microcarcinoma- surgery, observation etc.
• Management of central neck in such patients.
3:10 PM - 3:30 PM Afternoon Break with Exhibitors BALLY’S EVENT CENTER
AHNS acknowledges our Gold Level Donor for their support of the Afternoon Break
STRYKER
3:30 PM - 4:00 PM NCCN GUIDELINES DISCUSSION PLATINUM ROOM
Panel Moderator: David G. Pfister, MD
This session will review the NCCN practice guidelines development process. The management guidelines for poor risk adjuvant
disease and/or advanced oropharynx cancer will be discussed (time permitting).
“NCCN Guidelines Development Process”
David G. Pfister, MD
“Case Studies: Poor Risk Adjuvant and/or Advanced Oropharynx Cancer” David W. Eisele, MD, William M. Lydiatt, MD,
Ellie Maghami, MD and Bevan Yueh, MD
At the conclusion of this session, participants will be able to:
• Explain the NCCN practice guidelines development process.
• Apply the NCCN practice guidelines in patient management.
• Optimize treatment selection and performance.
www.ahns.info
29